Renovis renovis.com


Public lists: Pharma Startups (4732)

Renovis is a biopharmaceutical company that seeks to improve the lives of patients suffering from neurological disease with novel drugs that renew, restore, and repair the nervous system. The Company is developing REN-1654, a Phase II drug for neuropathic pain, and REN-213, a drug for post-operative pain that will enter Phase I later in 2003. Renovis will be entitled to future milestones and royalties in connection with the successful development of Cerovive, which is in pivotal Phase III clinic...Show all

Renovis is a biopharmaceutical company that seeks to improve the lives of patients suffering from neurological disease with novel drugs that renew, restore, and repair the nervous system. The Company is developing REN-1654, a Phase II drug for neurop...Show all

Company (Acquired)

Phone: 650-266-1400

Fax: +1 510 601 5201

Two Corporate Drive

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Renovis $171.1M May 9, 2008
See all 34 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Renovis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 22 investors

Competitors

Company Status Description Investors
See all 34 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Surgical implant devices incorporating porous surfaces Jul 24, 2014 Application